Catalyst Wire Dossier Catalyst Wire Dossier

MH004 Ointment

· Minghui Pharmaceutical (Hangzhou) Ltd
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for MH004 Ointment, covering 2025-09-18 to 2025-09-22. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 3 Study of MH004 Ointment in Patients With Mild to Moderate Atopic Dermatitis [Phase 3]

See pricing